197 related articles for article (PubMed ID: 29468820)
21. Why it is necessary to translate curcumin into clinical practice for the prevention and treatment of metabolic syndrome?
Sahebkar A
Biofactors; 2013; 39(2):197-208. PubMed ID: 23239418
[TBL] [Abstract][Full Text] [Related]
22. Molecular mechanisms underlying chemopreventive potential of curcumin: Current challenges and future perspectives.
Kumar G; Mittal S; Sak K; Tuli HS
Life Sci; 2016 Mar; 148():313-28. PubMed ID: 26876915
[TBL] [Abstract][Full Text] [Related]
23. Curcumin attenuates inflammatory response and cognitive deficits in experimental model of chronic epilepsy.
Kaur H; Patro I; Tikoo K; Sandhir R
Neurochem Int; 2015 Oct; 89():40-50. PubMed ID: 26190183
[TBL] [Abstract][Full Text] [Related]
24. Molecular targets of curcumin for cancer therapy: an updated review.
Kasi PD; Tamilselvam R; Skalicka-Woźniak K; Nabavi SF; Daglia M; Bishayee A; Pazoki-Toroudi H; Nabavi SM
Tumour Biol; 2016 Oct; 37(10):13017-13028. PubMed ID: 27468716
[TBL] [Abstract][Full Text] [Related]
25. Curcumin: therapeutical potential in ophthalmology.
Pescosolido N; Giannotti R; Plateroti AM; Pascarella A; Nebbioso M
Planta Med; 2014 Mar; 80(4):249-54. PubMed ID: 24323538
[TBL] [Abstract][Full Text] [Related]
26. Pharmacological basis for the role of curcumin in chronic diseases: an age-old spice with modern targets.
Aggarwal BB; Sung B
Trends Pharmacol Sci; 2009 Feb; 30(2):85-94. PubMed ID: 19110321
[TBL] [Abstract][Full Text] [Related]
27. Anti-inflammatory effect of combined tetramethylpyrazine, resveratrol and curcumin in vivo.
Chen L; Liu T; Wang Q; Liu J
BMC Complement Altern Med; 2017 Apr; 17(1):233. PubMed ID: 28449676
[TBL] [Abstract][Full Text] [Related]
28. Determining whether curcumin degradation/condensation is actually bioactivation (Review).
Jankun J; Wyganowska-Świątkowska M; Dettlaff K; Jelińska A; Surdacka A; Wątróbska-Świetlikowska D; Skrzypczak-Jankun E
Int J Mol Med; 2016 May; 37(5):1151-8. PubMed ID: 26985652
[TBL] [Abstract][Full Text] [Related]
29. Curcumin and liver disease.
Vera-Ramirez L; Pérez-Lopez P; Varela-Lopez A; Ramirez-Tortosa M; Battino M; Quiles JL
Biofactors; 2013; 39(1):88-100. PubMed ID: 23303639
[TBL] [Abstract][Full Text] [Related]
30. A novel chemically modified curcumin reduces inflammation-mediated connective tissue breakdown in a rat model of diabetes: periodontal and systemic effects.
Elburki MS; Moore DD; Terezakis NG; Zhang Y; Lee HM; Johnson F; Golub LM
J Periodontal Res; 2017 Apr; 52(2):186-200. PubMed ID: 27038334
[TBL] [Abstract][Full Text] [Related]
31. Curcumin Lowers Serum Lipids and Uric Acid in Subjects With Nonalcoholic Fatty Liver Disease: A Randomized Controlled Trial.
Panahi Y; Kianpour P; Mohtashami R; Jafari R; Simental-Mendía LE; Sahebkar A
J Cardiovasc Pharmacol; 2016 Sep; 68(3):223-9. PubMed ID: 27124606
[TBL] [Abstract][Full Text] [Related]
32. Curcumin and its topical formulations for wound healing applications.
Mohanty C; Sahoo SK
Drug Discov Today; 2017 Oct; 22(10):1582-1592. PubMed ID: 28711364
[TBL] [Abstract][Full Text] [Related]
33. Curcumin attenuates severity of premenstrual syndrome symptoms: A randomized, double-blind, placebo-controlled trial.
Khayat S; Fanaei H; Kheirkhah M; Moghadam ZB; Kasaeian A; Javadimehr M
Complement Ther Med; 2015 Jun; 23(3):318-24. PubMed ID: 26051565
[TBL] [Abstract][Full Text] [Related]
34. Protective effect of curcumin against chronic alcohol-induced cognitive deficits and neuroinflammation in the adult rat brain.
Tiwari V; Chopra K
Neuroscience; 2013 Aug; 244():147-58. PubMed ID: 23583655
[TBL] [Abstract][Full Text] [Related]
35. Curcumin: An Effective Inhibitor of Interleukin-6.
Ghandadi M; Sahebkar A
Curr Pharm Des; 2017; 23(6):921-931. PubMed ID: 27719643
[TBL] [Abstract][Full Text] [Related]
36. The Role of Curcumin in Prevention and Management of Metastatic Disease.
Bachmeier BE; Killian PH; Melchart D
Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29890744
[TBL] [Abstract][Full Text] [Related]
37. Curcumin: the Indian solid gold.
Aggarwal BB; Sundaram C; Malani N; Ichikawa H
Adv Exp Med Biol; 2007; 595():1-75. PubMed ID: 17569205
[TBL] [Abstract][Full Text] [Related]
38. Pharmacological actions of curcumin in liver diseases or damage.
Rivera-Espinoza Y; Muriel P
Liver Int; 2009 Nov; 29(10):1457-66. PubMed ID: 19811613
[TBL] [Abstract][Full Text] [Related]
39. Role of microRNAs in the Therapeutic Effects of Curcumin in Non-Cancer Diseases.
Momtazi AA; Derosa G; Maffioli P; Banach M; Sahebkar A
Mol Diagn Ther; 2016 Aug; 20(4):335-45. PubMed ID: 27241179
[TBL] [Abstract][Full Text] [Related]
40. Multitargeting by turmeric, the golden spice: From kitchen to clinic.
Gupta SC; Sung B; Kim JH; Prasad S; Li S; Aggarwal BB
Mol Nutr Food Res; 2013 Sep; 57(9):1510-28. PubMed ID: 22887802
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
